Bioventus Inc. (NASDAQ:BVS) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Bioventus Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
Bioventus Inc. (BVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 46,100 | $550,895 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.55 | 25,500 | Large Shareholder, Director | 6,939,357 | 2024-08-19 | Filing | |
| $8.55 | 80,000 | Large Shareholder, Director | 6,913,857 | 2024-08-16 | Filing | |
| $4.14 | 26,595 | Officer, Director | 26,595 | 2023-08-18 | Filing | |
| $4.14 | 13,290 | Officer, Director | 138,290 | 2023-08-18 | Filing | |
| $4.79 | 14,985 | Large Shareholder, Director | 6,833,857 | 2023-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.57 | 9,219 | Officer | 84,895 | 2024-06-21 | Filing | |
| $5.57 | 5,904 | Officer | 95,576 | 2024-06-21 | Filing | |
| $5.57 | 2,559 | Officer | 41,199 | 2024-06-21 | Filing | |
| $5.84 | 13,753 | Officer | 63,114 | 2024-06-17 | Filing | |
| $5.84 | 11,308 | Officer | 81,630 | 2024-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,021,324 | $68,622,377 | 16.98% | |
| 2. | 1,218,500 | $6,421,495 | 0% | |
| 3. | 505,574 | $2,664,375 | 0% | |
| 4. | 407,444 | $2,147,635 | 0% | |
| 5. | 363,804 | $1,917,247 | 0.04% |
News See All
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
Bioventus Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $-0.05. Bioventus Inc.
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Bioventus Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Dustin, and I will be your conference operator today. This time, I would like to welcome everyone to Bioventus Inc.
Bioventus Inc. (NASDAQ:BVS) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Bioventus, Inc. Second Quarter 2023 Earnings Conference Call. I will now turn the call over to your host for today, Mr.
Hedge Fund and Insider Trading News: Cathie Wood, Chase Coleman, Lansdowne Partners, Miller Value Partners, Metacapital Management, Picton Mahoney Asset Management, Nordea Asset Management, Boston Properties, Inc. (BXP), Barnwell Industries, Inc. (BRN), and More
London-based investment manager Lansdowne Partners LLP said on Wednesday it had agreed to acquire the $1.1 billion UK equities manager CRUX Asset Management, subject to regulatory approval, according ...
Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Bioventus Inc. First Quarter 2023 Earnings Conference Call.
Bioventus Inc. (NASDAQ:BVS) Q4 2022 Earnings Call Transcript
Operator: Good day. And welcome to the Bioventus Incorporated Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Here’s Why Bioventus (BVS) Declined in Q4
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Value Strategy” fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
15 Largest Orthopedic Companies in the World
The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to the lockdowns and restrictions during the COVID-19 pandemic.
Billionaire Hedge Funds
